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Purpose: Aphakia is the complete absence of any lens in the eye, either due to surgical removal of the lens as a result of
a perforating wound or ulcer, or due to a congenital anomaly. The purpose of this study was to elucidate the molecular
genetics for a large consanguineous Pakistani family with a clear aphakia phenotype.
Methods: The initial homozygosity screening of the family was extended to all the known autosomal recessive cataract
loci in order to exclude the possibility of surgical cataract removal leading to aphakia. The screening was performed using
polymorphic nucleotide repeat markers, followed by DNA sequencing of a possible candidate gene, the forkhead box
protein E3 gene (FOXE3). The identified mutation was counter-checked by a diagnostic restriction enzyme digest of all
the family members, and an analysis of the normal population.
Results: The initial homozygosity screening of 13 known autosomal recessive loci resulted in negative LOD (logarithm
of odds) scores. The aphakia phenotype suggested a mutation in FOXE3 close to the AR-locus 1p34.3-p32.2, and sequence
analyses revealed the nonsense mutation c.720C>A, changing cysteine 240 to a stop codon. Segregation in the family was
shown by diagnostic restriction enzyme digest, and marker analysis of another aphakia family from Madagascar carrying
the same mutation excluded the presence of a founder mutation. Clinical re-examination of the family was not possible
due to the escalating security concerns and internal displacement of the population in this region of Pakistan which has
prevailed for many months.
Conclusions: FOXE3 is responsible for the early developmental arrest of the lens placode, and the complete loss of a
functional FOXE3 protein results in primary aphakia. It can also be deduced that this mutation is quite primitive in origin
since the same mutation is responsible for the same phenotypic outcome in two families of geographically different descent.
Primary congenital aphakia is a rare congenital disorder
that  has  been  classified  histologically  into  primary  and
secondary forms. Primary aphakia appears due to the early
developmental  arrest  of  the  lens  placode  leading  to  the
complete absence of the lens, while secondary aphakia is
observed in cases where the lens is formed initially but is
subsequently  resorbed  perinatally  (OMIM  610256).  The
phenotypic  outcome  is  quite  diverse  in  these  two  forms
because of the different stages of onset. In primary aphakia,
the missing lens formation leads to severe congenital eye
malformations, including aplasia of the interior eye segment,
whereas secondary aphakia leads to less severe ocular defects.
Primary congenital aphakia is known to be caused by
mutations in the forkhead box protein E3 (FOXE3) gene in
both humans and mice [1-6]. FOXE3 is a member of the
forkhead family of genes; more than 40 FOX genes are known
in the human genome and  they are  transcription  factors
characterized  by  an  80–100  amino  acid  DNA  binding
Correspondence to: Lars Hansen, Section IV, Department of Cellular
and  Molecular  Medicine,  The  Panum  Institute,  University  of
Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark;
Phone: +45 35327825; FAX: +45 35327845; email: lah@sund.ku.dk
forkhead motif. The human FOXE3 maps to chromosome
1p33, and was initially named FREAC-8 (forkhead-related
activator 8) or FKHL12 (forkhead, drosophila, homolog-like
12)  [7].  The  Fox  proteins  exhibit  very  high  functional
diversity, and are involved in very early key developmental
processes, including the formation of the notochord and the
establishment  of  the  body  axis,  carnio-pharyngeal
development,  hair  development,  hearing,  and  speech  and
language [8], and several Fox proteins have been shown to be
expressed  during  eye  development  [9].  The  function  of
FOXE3 in lens development has been extensively studied in
mice where homozygous null mutations result in congenital
aphakia with the absence of lens development [1,2,10,11]. In
humans, homozygous FOXE3 mutations have been associated
both with recessive inherited congenital primary aphakia [3,
4],  and  the  dominant  inheritance  of  ocular  dysgenesis,
cataracts  and  Peters’  anomaly  [5,6].  Here,  we  report  the
characterization  of  a  FOXE3  mutation  identified  in  a
consanguineous  Pakistani  family  that  results  in  primary
congenital aphakia.
METHODS
Biologic  sample:  A  large  inbred  family  with  congenital
primary aphakia was ascertained from a remote village of
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549Pakistan (Basti Moza Kotla Mosa, District Bahawalpur, South
Punjab)  having  many  affected  individuals.  The  mode  of
inheritance as evident from the segregation of disease alleles
in  the  pedigree  was  autosomal  recessive.  Venous  blood
samples were collected from fifteen members of the family,
depending on their availability and willingness to participate
in  the  study.  Genomic  DNA  was  extracted  following  the
standard phenol:chloroform method.
STS marker analysis: All known autosomal recessive cataract
loci were enlisted (Table 1) and initially screened using two
or  more  STS  (Sequence-Tagged-Site)  marker  systems  for
each  locus  in  order  to  exclude  the  possibility  of  cataract
involvement  in  the  phenotype.  A  3-primer  STS  marker
protocol  was  developed  for  the  fragment  analyses  using
ABI3130XL  and  GeneMapper  3.0  technology  (Applied
Biosystems, Foster City, CA). The 3-primer labeling system
uses a FAM labeled primer (FAM-TGA CCG GCA GCA
AAA TT), and the identical primer sequence was added 5′ to
one of the genome specific PCR primers. All oligonucleotides
were  purchased  from  TAG  Copenhagen  (Copenhagen,
Denmark).  Briefly,  for  the  3-primer  protocol,  the  primer
concentrations were: FAM-primer 0.8 μM, forward extended
primer 0.1 μM, and reverse primer 0.25 μM applying standard
PCR  conditions  using  Ampliqon  III  Taq  polymerase
(Ampliqon,  Copenhagen,  Denmark).  The  PCR  conditions
were as follows: pre-denaturation 95 °C, 10 min; then 30
cycles 95 °C, 1 min; 60 °C (or specific annealing temperature
tested by temperature gradient), 1 min; 72 °C, 1 min followed
TABLE 1. LIST OF AUTOSOMAL RECESSIVE CATARACT LOCUS AND STS MARKERS.
Locus position Markers selected Gene Ethnicity Reference
1p34.3-p32.2 D1S255, D1S2892, D1S197 Unknown Pakistan [13]
1q21.1 D1S442, D1SGJA5-GJA8* GJA8 (CX50) South India [14]
3p22–24.2 D3S1298 Unknown Arab [15]
6p24.2 D6S470, D6S1034 GCNT2 Arab [16]
9q13-q22 D9S768, D9S152 CAAR Pakistan [17]
14q24.3 D14S986, D14S1025, D14S1047, D14S273 CHX10 Turkey, UAE [18]
16q22.1 D16S3019, D16S3086, D16S421, D16S3107, D16S3095 HSF4 Pakistan, China, Tunisia [17,19]
19q13 D19S416 Unknown Pakistan [20]
19q13.33 D19S246 LIM2 Iraqi Jewish [21]
20p12.1 D20S860 BFSP1 India [22]
22q11.23 D22S421 CRYBB3 [23]
22q12.1 D22S315, D22S1167 CRYBB1 Israel [24]
21q22.3 D21S1411, D21S1890, D21S1885 CRYAA Jewish Persian [25]
TABLE 2. PCR SEQUENCING PRIMERS FOR FOXE3.
Forward primer Reverse primer PCR length
FOXE3_ex1.1f TGTCCATATAAAGCGGGTCG FOXE3_ex1.1r ATGTACGAGTAGGGCGGCTT 298 bp
FOXE3_ex1.2f TTCTCTGGCTTCCCTGCC FOXE3_ex1.2r TCGGTGATGAAGCGGTAGAT 272 bp
FOXE3_ex1.3f AAGCCGCCCTACTCGTACAT FOXE3_ex1.3r TCGTTGAGCGTGAGATTGTG 170 bp
FOXE3_ex1.4f TTCATCACCGAACGCTTTGC FOXE3_ex1.4r AGGAAGCTGCCGTTGTCGAA 185 bp
FOXE3_ex1.5f AAGGGCAACTACTGGACGCT FOXE3_ex1.5r TAGCTCCGGCTGCAGGTT 267 bp
FOXE3_ex1.6f TCTGTTCAGCGTCGACAG FOXE3_ex1.6r CAGGTCGCACAGGTGCC 351 bp
TABLE 3. STS MARKERS USED FOR FINE MAPPING OF THE HOMOZYGOUS REGION AT 1P33.
STS marker Physical position chromosome 1 (hg18)
D1S496 35,179,917
D1S2729 36,843,493
D1S255 37,422,301
D1S2892 39,963,503
D1S2130 41,590,073
FOXE3 47,654,331 - 47,656,311
D1S2720 47,680,375
D1S197 50,523,064
D1S2652 55,239,419
D1S2890 57,645,988
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550by 8 cycles 95 °C, 1 min; 50 °C, 1 min; and 72 °C, 1 min. Total
PCR volumes were adjusted to 12 μl using 10–20 ng template
DNA.  Two  point  LOD  scores  were  calculated  using  the
LIPED program [12].
DNA sequencing of FOXE3: This gene consists of a single
exon  and  was  sequenced  for  genomic  variants  by  PCR
amplification  using  overlapping  sets  of  primers  (Table  2)
covering the coding region. This was followed by direct DNA
sequencing on ABI3130 XL using BigDye ver1.1 technology
(Applied  Biosystems).  The  sequences  were  checked  for
possible variants using ChromasPro (Technelysium Pty Ltd.,
Tewantin, Australia) by alignment to the reference sequences
(GenBank NM_012186 and NP_036318). The sequencing
primers were purchased from TAG Copenhagen, and the Taq
DNA  polymerases  from  Qiagen  (Hilden,  Germany)  and
Invitrogen (Carlsbad, CA). The PCR products were analyzed
Figure  1.  Pedigree  and  haplotype
analysis  of  CT1.  A:  The  pedigree  of
family  CT1  shows  a  high  degree  of
consanguinity  in  7  generations.  Two
haplotypes  are  represented  in  the
pedigree; the spouse CT1–14 carries the
identical  mutation  and  shares  the
identical haplotype distal to the FOXE3
gene. The two haplotypes are shown as
black or black and gray. Symbols: open
circles  or  squares  are  healthy
individuals,  filled  symbols  represent
affected  individuals  and  half  filled
symbols  represent  carriers.  B:
Restriction  enzyme  digests  of  all  the
family  members  where  DNA  was
available demonstrate the segregation of
the  mutation  with  the  disease  in  the
family.  The  restriction  enzyme  DdeI
recognizes the mutation and cleaves the
204 bp band into two fragments of 131
bp and 73 bp. An additional 75 bp band
is observed in all individuals.
TABLE 4. LOD SCORE FOR FOXE3 MUTATIONS AND MARKERS.
STS marker                                                                                      θ
Order 0.0 0.01 0.05 0.1 0.2 0.3 0.4
D1S2130 2.40 2.30 2.00 1.70 1.00 0.50 0.10
c.720C>A 6.62 6.50 6.00 5.35 3.97 2.51 1.10
D1S2720 1.60 1.60 1.40 1.10 0.70 0.40 0.10
Mut p=0.001
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551by 2% agarose gel-electrophoresis, 1× TBE and the DNA was
stained with ethidium bromide.
Restriction  enzyme  digest:  The  mutation  was  counter-
confirmed using a restriction enzyme digest with DdeI (New
England Biolabs, Ipswich, MA) of the PCR product generated
by  the  primer  pair  FOXE3–1.6  (Table  2)  under  standard
conditions in a volume of 20 µl, and the cleaved products were
analyzed by 2% agarose gel-electrophoresis, 1× TBE and the
DNA was stained with ethidium bromide.
RESULTS AND DISCUSSION
All  the  available  DNA  samples  for  family  CT1  were
genotyped for all possible autosomal recessive cataract loci
(Table  1)  in  order  to  rule  out  the  possibility  of  cataract
involvement  in  the  resulting  aphakic  eyes.  Initial
homozygosity  was  traced  on  chromosome  1p33  by  STS
markers D1S255, D1S2892, and D1S197. Haplotype analysis
based  on  more  adjacent  markers  revealed  several
polymorphisms  throughout  the  family  which  helped  to
identify a narrow conserved region around the FOXE3 gene
(Table  3  and  Figure  1A).  All  the  affected  individuals
presented homozygous alleles except for individuals CT1–7
and CT1–8, whereas the phenotypically normal individuals
were either carriers of heterozygous alleles or homozygous.
Interestingly, part of the disease haplotype was even brought
in from outside the main kindred by CT1–14, suggesting that
either the carrier was related to the CT1 family, or that disease
carriers are highly prevalent in the region. Individual CT1–14
carried the identical disease haplotype proximal to the FOXE3
locus but a different haplotype distal to the FOXE3 locus
(Figure 1A), which suggested a recombination between the
FOXE3 locus and the marker D1S2130 (see Table 3). LOD
score calculations both for the FOXE3 mutation and the two
STS markers (Table 4) demonstrated positive LOD scores,
with a maximum of Z=6.62 at θ=0.0 for the FOXE3 mutation.
Sequencing  of  the  coding  region  of  FOXE3  in  one
affected individual using overlapping primer pairs (Table 2)
revealed a C>A single base substitution (c.720C>A) leading
to a nonsense mutation in the cysteine 240 codon (p.Cys240X)
as the underlying genetic cause of the disease phenotype. The
restriction enzyme DdeI (recognition site 5′-CTNAG-3′) was
chosen to confirm the mutation which cleaves the wild type
allele  of  204  bp  into  fragments  of  73  bp  and  131  bp,
respectively.  Restriction  enzyme  cleavage  of  the  family
demonstrated segregation of the mutation with the disease
trait, and carriers were heterozygote for the wild type and the
mutant alleles (Figure 1B) confirming the recessive mode of
inheritance adopted by mutation.
The identical mutation was first reported in an inbred
family from Madagascar [3]. Presenting the same underlying
mutation, both families share the same phenotype showing the
complete absence of the lens (Figure 2). Marker analyses were
set for one individual from each of the families to see if the
shared FOXE3 mutation originated from the same ancestral
founder.  No  informative  SNPs  were  found  in  the  nearby
vicinity of FOXE3 locus, and so several STS markers in the
region were analyzed in one affected person from each family.
The  haplotype  analysis  demonstrated  different  haplotypes
segregating in the two families (Figure 3B). As a consequence,
it  is  very  likely  that  the  p.C240X  mutation  occurred
independently in the two families.
The expression of the FOXE3 gene is limited to the lens,
but mutations in FOXE3 result in various ocular phenotypes
leading  either  to  dominant  or  recessive  inheritance  [3-6].
Figure  2.  The  individual  CT1–11
showing  complete  congenital  primary
aphakia.
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552Mutations in FOXE3 have been reported in 8 families so far,
including CT1 and a total of 7 different mutations have been
identified  (Figure  3C).  Four  mutations  characterized  in
families  with  dominant  inheritance  are  reported  in
combination with Peters’ anomaly, cataract and other ocular
dysgenesis [4-6], and four families, including CT1, manifest
recessive  inheritance  in  association  with  the  more  severe
phenotype primary aphakia [3,4].
All  carriers  in  family  CT1  were  healthy  as  reported
previously for the three other recessive families [3,4]. This
suggests the pathogenic nature to be a null mutation with loss
of function rather than haploinsufficiency as suggested earlier
[4,5]. Unfortunately, it has not been possible to re-examine
the CT1 family after identification of the mutation as a result
of escalating security concerns, and internal displacement of
the population in the region of Pakistan where the family
resides.
FOXE3 is a single exon gene encoding a 319 amino acid
protein,  and  the  recessive  p.Cys240X  mutation  results  in
premature termination of translation and a truncated protein
carrying the forkhead domain (Figure 3C). The very initial
expression of FOXE3 is observed in the lens-forming surface
ectoderm (E 9.5), and maintains its presence throughout lens
placode formation, and in later processes too as invagination
and separation from the ectoderm above. Later during the
development, the expression of FOXE3 is switched off from
the  differentiating  lens  fiber  cells,  restricting  itself  to  the
anterior lens epithelium (E 14.5) where its expression remains
confined throughout the life of the subject [2,4]. The complete
lack of a functional FOXE3 protein product may explain the
complete  lack  of  lens  development  resulting  in  aphakia
observed both in association with the p.Cys240X mutation
found in two families as well as for the two other recessive
mutations (Figure 3C). Finally, it is noteworthy that all the
reported recessive families were consanguineous, and that
three out of four were of Pakistani descent.
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